Biosimilars 

• Biosimilar Operational Readiness: Current and Future Market Landscape

• Biosimilars in Vision: Addressing Drug Trends and Managed Care Strategies

• Biosimilar Operational Readiness: Managed Care Stakeholder Preparation for Market Expansion

Drugs, Diseases, and the Managed Care Impact 

• AMCP Partner Session: Managed Care Perspective on HIV Prevention - A Public Health Priority

• 2022-2023 Health Care and Pharmaceutical Marketplace Trends

• IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer Considerations

• Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management

• Rare Disease Spotlight: Hemophilia Treatment Advances

• Managed Care Approaches to Equitable Access to Recombinant Adeno-Associated Virus (rAAV) Gene Therapy

Legislative and Regulatory Trends 

• Federal Legislative and Regulatory Update - AMCP 2023

• State Legislative and Regulatory Update - AMCP 2023

Focus on Managed Care Pharmacy 

• Prior Authorization Criteria: Looking Beyond Clinical Trial Populations

• Challenges and Opportunities in Collecting Data to Address Health Disparities

• Drug Pipeline - Traditional Pharmaceuticals

• AMCP Talks: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions

Managed Care Research in Action 

• Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease

Making the Way for Innovation 

• The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications

• Cancer Drug Dose Rounding - Decreasing Drug Cost, Minimizing Waste and Improving Efficiency